6,7-dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one-13C3; 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one-13C3; BL-4162A-13C3; BMY-26538-01-13C3; Agrylin-13C3; Tromboreductin-13C3; Xagrid-13C3
Anagrelide-13C3 is a fully characterized chemical compound used as a reference standard of API Anagrelide. The standard offered is compliant with regulatory guidelines. Anagrelide-13C3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1219531-58-4
